Results 131 to 140 of about 4,617,382 (195)

Dynamic Monitoring of ADAMTS-13 Activity for Differential Diagnosis Across the Spectrum of Sepsis-Associated Thrombotic Microangiopathies. [PDF]

Mediterr J Hematol Infect Dis
Liu Y, Lu F, Ji B, Song W, Shen H, Xu Y, Yang B.   +6 more
europepmc   +1 more source

ADAMTS-13-regulated nuclear factor E2-related factor 2 signaling inhibits ferroptosis to ameliorate cisplatin-induced acute kidney injuy. [PDF]

Bioengineered, 2021
Meng X, Huang W, Mo W, Shu T, Yang H, Ning H.   +5 more
europepmc   +1 more source

Quantification of von Willebrand factor and ADAMTS-13 after traumatic injury: a pilot study. [PDF]

Trauma Surg Acute Care Open, 2021
MacArthur TA, Goswami J, Moon Tasson L, Tischer A, Bailey KR, Spears GM, Dong JF, Auton M, Kozar R, Park MS.   +9 more
europepmc   +1 more source

Recombinant ADAMTS-13 for congenital and immune thrombotic thrombocytopenic purpura in pregnancy. [PDF]

Blood Vessel Thromb Hemost
Howells L, Lissack M, Wykes C, Thomas MR, Scully M.   +4 more
europepmc   +1 more source

ADAMTS-13 Behavior in Thrombocytopenia of Infectious Origin in ICU Patients. [PDF]

Indian J Crit Care Med
Gontla VDK, Samavedam S, Aluru N, Rudravarapu R, Pabba S, Shaik MN.   +5 more
europepmc   +1 more source

ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19. [PDF]

Thromb Res, 2021
Pascreau T, Zia-Chahabi S, Zuber B, Tcherakian C, Farfour E, Vasse M.   +5 more
europepmc   +1 more source

A chronic recurrent course of moschcowitz disease

Терапевтический архив, 2008
I I Kalinina, O V Stalina, V V Ryzhko, N V Tsvetaeva, S A Vasil'ev, V I Petrova   +5 more
doaj  

The impact of the COVID-19 pandemic on incidence and clinical presentation of thrombotic microangiopathies: data from a laboratory centralizing ADAMTS-13 testing in Quebec. [PDF]

Orphanet J Rare Dis
Merlen C, Thouzeau-Benghezal S, Pépin E, Guay S, Lapeyraque AL, Cambier A, Rivard GE, Troyanov S, Bonnefoy A.   +8 more
europepmc   +1 more source

Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin. [PDF]

Clin Appl Thromb Hemost, 2021
Bashir DA, Da Q, Pradhan S, Sekhar N, Valladolid C, Lam F, Guffey D, Goldman J, Desai MS, Cruz MA, Allen C, Nguyen TC, Vijayan KV.   +12 more
europepmc   +1 more source

A mutant complement factor H (W1183R) enhances proteolytic cleavage of von Willebrand factor by ADAMTS-13 under shear. [PDF]

J Thromb Haemost
Cao W, Liu Y, Zhang XF, Zheng XL.
europepmc   +1 more source